# Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health

> **NCT02137408** · NA · WITHDRAWN · sponsor: **Children's Hospital Medical Center, Cincinnati**

## Conditions studied

- Hypertension in Pregnancy

## Interventions

- **DIETARY_SUPPLEMENT:** Docosahexaenoic acid 200 mg
- **DRUG:** Docosahexaenoic acid 1000 mg

## Key facts

- **NCT ID:** NCT02137408
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-12
- **Primary completion:** 2015-11
- **Final completion:** 2016-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI no longer at Institution
- **Last updated:** 2014-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02137408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02137408, "Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02137408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*